Welcome speeches
Adriana Ceci, Fondazione per la Ricerca Farmacologica Gianni Benzi Onlus (Italy)
Annagrazia Altavilla, European Association of Health Law (France)
Laurence Lwoff, Head of the Bioethics Unit – Human Rights Directory – Council of Europe (France)

INTRODUCTORY SESSION

Models of Governance for Innovation in Medicine and Health Research
Siobhán O’ Sullivan, Royal College of Surgeons (Ireland)

SESSION I – Innovative medicine and research

Chairman
Timo Minssen, Centre for Advanced Studies in Biomedical Innovation Law (CeBIL), University of Copenaghen (Denmark)

Access to Personal Data for Scientific Research in the perspective of innovative medicines
Jean Herveg, University of Namur (Belgium)

Legal and Regulatory issues dealing with paediatric specificity in the EPTRI (European Paediatric Translational Research) framework
Olga Tzortzatou, Biomedical Research Foundation of the Academy of Athens (Greece)

Intellectual Property Protection of Genetic Material and Information in the Pharmaceutical Sector? – Legal Questions on Genetic Material and Genome Sequencing between Innovation, Protection and Sharing
Claudia Seitz, University of Basel (Switzerland), University of Bonn’s Centre for the Law of Life Sciences (Germany)

Break

SESSION II – Access to health care and innovation

Chairman
Joaquin Cayon De Las Cuevas, University of Cantabria (Spain)

Health Technology Assessment (HTA) and access policies
Verena Stühlinger, University for Health Sciences, Medical Informatics and Technology (UMIT) – (Austria)

Machine Learning Systems applied to health data
Fedele Bonifazi, Fondazione per la Ricerca Farmacologica Gianni Benzi Onlus (Italy)

Exploring solutions to foster ATMP’s development and access to patients in Europe
Vincenzo Salvatore, University of Insubria (Italy)

SESSION III – Empowerment and patients’ rights in innovative healthcare

Chairman
Tom Goffin, Ghent University (Belgium)

Orphan medicinal products and health budgets: our role as patient advocates
François Houyez, EURORDIS (France)

Health vulnerability and the European framework on access to orphan medicines
Eloise Gennet, INSERM UMR 1027, University of Toulouse (France)

Discussion and conclusion

Chairman
Enrico Bosone, SIARV (Italy)

Annagrazia Altavilla, Espace Ethique PACA-Corse/AP-HM, European Association of Health Law (France)